4//SEC Filing
Nosenzo John 4
Accession 0000899243-22-006332
CIK 0001665988other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 8:41 PM ET
Size
8.5 KB
Accession
0000899243-22-006332
Insider Transaction Report
Form 4
Nosenzo John
Chief Commercial Officer
Transactions
- Tax Payment
Class A Common Stock
2022-02-10$12.88/sh+24,205$311,760→ 42,434 total - Exercise/Conversion
Phantom Profit Units
2022-02-10−66,139→ 0 total→ Class A Common Stock (66,139 underlying) - Exercise/Conversion
Class A Common Stock
2022-02-10+66,139→ 66,639 total
Footnotes (1)
- [F1]Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering.
Documents
Issuer
Bioventus Inc.
CIK 0001665988
Entity typeother
Related Parties
1- filerCIK 0001835973
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 8:41 PM ET
- Size
- 8.5 KB